News

Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia

Presentations feature real-world experience and clinical evidence in lower-risk MDS, underscoring growing global scientific engagement with imetels…

Geron to Present at Upcoming Investor Conferences

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026